Effectiveness of Qualia NAD+ Supplementation on Intracellular NAD Levels
ConditionNAD+ Levels in the Blood
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-65
SponsorQualia Life Sciences
About this trial
The goal of this clinical trial is to determine if Qualia NAD+ effectively increases NAD+ levels in the blood and to evaluate its safety.
Researchers will compare Qualia NAD+ to a placebo (a look-alike substance that contains no active drug) to assess its efficacy in increasing NAD+ levels in the blood.
Participants will:
Take Qualia NAD+ or a placebo every day for 4 weeks. Undergo blood tests before and after the trial.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Qualia NAD+
Dietary supplementQualia NAD+ is a novel dietary supplement, formulated to support the maintenance and enhancement of intracellular NAD levels.
Placebo
Other interventionRice flour
Treatment groups
200 Participants
are divided into 2 treatment groupsGroup A: Qualia NAD+Experimental treatment 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
NAD+ Levels in the Blood
Time frame
4 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov